Hong Kong stocks movement | 3SBIO (01530) rose nearly 8% during the session as SSGJ707 clinical data was excellent, and expectations for overseas business development provide significant flexibility.

3SBIO (01530) rose nearly 8% during the trading session, and as of the writing, it has increased by 6.34%, priced at 8.05 HKD, with a transaction value of 0.447 billion HKD.

Zhitong FinanceMar 10 02:46 ET

3SBIO (01530.HK) plans to hold a Board of Directors meeting on March 25 to approve the annual performance.

Gelonghui, March 7 — 3SBIO (01530.HK) announced that it will hold a Board of Directors meeting on March 25, 2025 (Tuesday) to review and approve the annual performance of the company and its subsidiaries for the year ending December 31, 2024, and their release, and consider the distribution of the final dividend for the year ending December 31, 2024 (if any).

Gelonghui FinanceMar 7 04:06 ET

3SBIO: NOTICE OF BOARD MEETING

HKEXMar 7 03:52 ET · Announcements

National People's Congress representative, Zhao Jing of Shandong Buchang Pharmaceuticals: "The 'AI+' is reaching a critical point of explosion. It is recommended to utilize AI to empower the inheritance and innovation of Traditional Chinese Medicine | Two

① Zhao Jing, a representative of the National People's Congress and Vice Director of Shandong Buchang Pharmaceuticals, brought the proposal "Utilizing AI to Empower the Inheritance and Innovation of Traditional Chinese Medicine and Build a New Pattern of Development for Traditional Chinese Medicine with 'Asia Vets + Technology'" to this year's Two Sessions, aiming to promote the intelligent upgrade of the Traditional Chinese Medicine industry through AI technology. ② Zhao Jing stated that the development of large models like DeepSeek has indeed pushed the integration of Traditional Chinese Medicine and AI to a critical point of explosion.

cls.cnMar 6 20:48 ET

The investment secrets in the government work report: Analyzing the collaborative logic of the Global Strategy and policies of Guoshengtang (2273.HK).

The report clearly states to strengthen basic Medical and health services.

Gelonghui FinanceMar 5 20:15 ET

The bull market for Hong Kong stocks has begun; how to identify the certainty of value growth?

At present, the technical bull market in the Hong Kong stock market is becoming the focus of attention for global investors.

Gelonghui FinanceMar 3 19:44 ET